Plasma manufacturing drives CSL
A big jump in the volume of plasma produced by biotechnology giant CSL has created positive momentum for the Melbourne company as it continues its emergence from the global pandemic. The company reported a 36 percent increase in plasma collection in the first half – plasma collections sank during the pandemic as Covid restrictions affected…











